An LC-MS/MS Method Development and Validation for the Quantification of Infigratinib in K2EDTA Human Plasma. (2024). International Journal of Pharmaceutical Sciences and Drug Research, 16(1), 86-91. https://doi.org/10.25004/IJPSDR.2024.160112